What is the EPS estimate for Novo Nordisk A/S's next earnings report?

The consensus EPS estimate for Novo Nordisk A/S's Q3 2026 earnings report is 0.75. Analysts expect revenue of 11.09B.

How did Novo Nordisk A/S perform in its last earnings report?

On 2026-08-04, Novo Nordisk A/S reported EPS of 0.74 and -4.44% EPS surprise. Revenue was 12.21B, compared with the consensus estimate of 11.09B.

What does an earnings surprise mean?

An earnings surprise is the difference between a company's reported EPS or revenue and the analysts' consensus estimate. A positive surprise means results exceeded expectations, while a negative surprise means results fell short.

How can earnings reports affect NVO stock?

Earnings reports can increase volatility in NVO stock, especially when reported EPS, revenue or company guidance differs from market expectations. An earnings beat does not always lead to a price increase, as investors also consider the outlook, valuation and broader market conditions.

Novo Nordisk A/S (NVO) Earnings Date & Reports & Earnings News

Novo Nordisk A/S Earnings Dates & Reports

This page offers detailed Novo Nordisk A/S earnings data including the latest Novo Nordisk A/S earnings report, the upcoming Novo Nordisk A/S earnings date, historical data and Novo Nordisk A/S earnings call news.

NVO Latest Quarter’s Earnings

Announce Date8/4/2026

EPS Actual (USD)0.74

Revenue Actual (USD)12.21B

NVO Upcoming Quarter's Earnings

Announce Date11/4/2026(Pre-Market)

EPS Forecast (USD)0.75

Revenue Forecast (USD)11.09B

NVO FY2025 Earnings

EPS (YoY)3.485.93%

Revenue (YoY)46.70B10.88%

Novo Nordisk A/S (NVO) Earnings History

Release Date	Period End	EPS/Forecast	Revenue/Forecast	EPS Surprise %	Revenue Surprise %
8/4/2026	06/2026	0.74/0.74	12.21B/10.72B	-1.17%	13.83%
5/6/2026	03/2026	1.71/0.92	15.17B/10.89B	87.00%	39.34%
2/3/2026	12/2025	0.94/0.86	12.34B/11.62B	10.14%	6.21%
11/5/2025	09/2025	0.71/0.68	11.74B/11.64B	3.03%	0.86%
8/6/2025	06/2025	0.91/0.92	11.67B/11.79B	-1.43%	-1.02%
5/7/2025	03/2025	0.92/0.96	11.01B/12.25B	-3.80%	-10.13%
2/5/2025	12/2024	0.91/0.91	12.25B/12.40B	-0.42%	-1.17%
11/6/2024	09/2024	0.90/0.93	10.50B/11.05B	-2.80%	-4.91%

Novo Nordisk A/S